⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Qointa and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Qointa
↗Puurs-Sint-Amands, Belgium
Qointa is a specialized provider of solutions and services for the regulated life sciences industry, including pharma, biotech, and medtech sectors. The company focuses on accelerating innovation and ensuring regulatory compliance through digital transformation, quality assurance, data integrity, and software development.
Their service offerings include digital health technology deployment for clinical trials, EU Authorized Representative (EC REP) services, and computerized system validation. Qointa bridges the gap between medical science, clinical practice, and healthcare technology to help clients navigate complex regulatory landscapes like FDA and EU requirements.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Clinical Trial Technology & Regulatory Consulting
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Modalities:Digital Health, Software as a Medical Device (SaMD)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Stefanini (Partnership to enhance life sciences services)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Rudiger Mees - CEO
Marc Waeterschoot - Founder
Scientific Founders:Marc Waeterschoot
LINKS
Website:qointa.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Qointa. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.